Learn, Analyse & Invest
only with

+91

Download Orca

To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Sai Life Sciences Ltd.

Sai Life Sciences

₹ 0.00

0.00 (0.00)%

NSE

BSE

Healthcare

Small-cap - With a market cap of ₹203.44 Cr.

EX-Date	Purpose
06 02 2025	Quarterly Results
13 05 2025	Audited Results
07 08 2025	Quarterly Results
06 11 2025	Quarterly Results
05 02 2026	Quarterly Results

News

06-FEB-2026

Sai Life Sciences’ consolidated net profit jumps 86% in Q3

The consolidated total income of the company increased by 25.83% at Rs 564.84 crore for Q3FY26

12:12 PM

29-JAN-2026

Sai Life Sciences collaborates with Mabtech

The collaboration is to advance immunology research with EYRA Platform at Sai Boston Site

09:50 AM

19-SEP-2025

Sai Life Sciences opens Unit VI facility for veterinary API production in Karnataka

With this expansion, the company aims to provide efficient and scalable manufacturing solutions to leading global animal health companies

11:53 AM

28-AUG-2025

Sai Life Sciences completes Phase II of PB-11 at API manufacturing facility in Karnataka

This expansion has taken the company’s total installed reactor capacity at the Bidar facility to around 700 KL

03:16 PM

20-JUN-2025

Sai Life Sciences commence commercial operations of Unit IV Bidar facility in Karnataka

This is the second and final phase of the overall capacity addition of 195 kL

03:09 PM

14-MAY-2025

Sai Life Sciences reports 57% rise in Q4 consolidated net profit

The total consolidated income of the company increased by 33.12% at Rs 589.11 crore for Q4FY25

03:30 PM

04-APR-2025

Sai Life Sciences sets up Peptide Research Center in India

The new Peptide Research Center will be integrated with company’s end-to-end discovery services, spanning synthetic and medicinal chemistry, biology, DMPK, and toxicology

02:58 PM

27-JAN-2025

Sai Life Sciences inks pact to acquire land along with certain building structures in Shamirpet

The said investment will be funded from internal accruals

09:15 AM

06-NOV-2024

Sai Life Sciences gets SEBI’s nod to raise Rs 5,000 crore via IPO

Of the IPO proceeds, funds to the tune of Rs 600 crore will be used for debt payment and a portion will be used for corporate general purposes

03:10 PM